The reported statements, read against the company's own industry.
Financials view
Market Capitalization
8.27BCNY
1.24B · vs all stocks (USD)
Updated Oct 21, 2026
Revenue (TTM)
879.87MCNY
131.88M · vs all stocks (USD)
Updated Oct 21, 2026
Profit Margin
-0.95%
Updated Oct 21, 2026
Beta
1.55x
vs all stocks
Updated Oct 21, 2026
52-Week Change
109.01%
vs all stocks
Updated Oct 21, 2026
Market Capitalization
8.27BCNY
1.24B · vs all stocks (USD)
Updated Oct 21, 2026
Enterprise Value
10.22BCNY
1.53B · vs all stocks (USD)
Updated Oct 21, 2026
Forward P/E
137.87x
Updated Oct 21, 2026
Price to Sales (TTM)
8.95x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 9.4×.Updated Oct 21, 2026
Price to Book (MRQ)
5.17x
Updated Oct 21, 2026
Enterprise to Revenue
11.61x
Updated Oct 21, 2026
Enterprise to EBITDA
58.22x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 110.17×.Updated Oct 21, 2026
Gross Margin
40.97%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 30.45%.Updated Oct 21, 2026
Profit Margin
-0.95%
Updated Oct 21, 2026
Operating Margin
18.60%
Updated Oct 21, 2026
Return on Assets (TTM)
0.46%
Updated Oct 21, 2026
Return on Equity (TTM)
-0.71%
Updated Oct 21, 2026
Revenue (TTM)
879.87MCNY
131.88M · vs all stocks (USD)
Updated Oct 21, 2026
Revenue per Share (TTM)
5.66CNYUpdated Oct 21, 2026
Quarterly Revenue Growth
34.80%
Updated Oct 21, 2026
Gross Profit (TTM)
267.91MCNY
40.16M · vs all stocks (USD)
Updated Oct 21, 2026
EBITDA (TTM)
92.73MCNY
13.90M · vs all stocks (USD)
Updated Oct 21, 2026
Net Income (TTM)
-8.32MCNY
-1.25M · vs all stocks (USD)
Updated Oct 21, 2026
Quarterly Earnings Growth (YoY)
115.20%
Updated Oct 21, 2026
Operating Cash Flow (TTM)
395.67MCNY
59.31M · vs all stocks (USD)
Updated Oct 21, 2026
Levered Free Cash Flow (TTM)
-2.48BCNY
-371.25M · vs all stocks (USD)
Updated Oct 21, 2026
5-Year Average Dividend Yield
0.13%
vs all stocks
Updated Oct 21, 2026
Payout Ratio
22.22%
Updated Oct 21, 2026
Minority Interest (Equity)
-336.40KCNYFY2025 · Dec 31, 2025
Revenue
852.33MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
609.21MCNYFY2025 · Dec 31, 2025
Gross Profit
243.13MCNYFY2025 · Dec 31, 2025
Operating Income
71.10MCNY
10.66M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
8.95MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-2.96MCNYFY2025 · Dec 31, 2025
Net Income
11.91MCNYFY2025 · Dec 31, 2025
EBIT
18.28MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
140.74MCNYFY2025 · Dec 31, 2025
Research & Development
43.14MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
50.14MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
3.31MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
2.74MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
9.33MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.0900CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.0900CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
151.93MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
151.93MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
11.91MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
1.76MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-46.61MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-1.21BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
475.75MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
11.91MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
10.21MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-93.15MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
24.43MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-1.17BCNYFY2025 · Dec 31, 2025
Purchase of Investments
-1.15BCNYFY2025 · Dec 31, 2025
Sale of Investments
1.46BCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-851.58MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
1.14BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-31.56MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-11.54MCNYFY2025 · Dec 31, 2025
Other Financing Charges
6.60MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
1.10BCNYFY2025 · Dec 31, 2025
Shares Outstanding
153.71MSharesUpdated Oct 21, 2026
Float Shares
96.23MSharesUpdated Oct 21, 2026
% Held by Insiders
42.57%
vs all stocks
Updated Oct 21, 2026
% Held by Institutions
1.91%
vs all stocks
Updated Oct 21, 2026
Total Cash (MRQ)
2.25BCNY
336.67M · vs all stocks (USD)
Updated Oct 21, 2026
Total Cash per Share (MRQ)
14.61CNYUpdated Oct 21, 2026
Total Debt (MRQ)
4.59BCNY
687.94M · vs all stocks (USD)
Updated Oct 21, 2026
Total Debt to Equity (MRQ)
3.02x
Updated Oct 21, 2026
Current Ratio (MRQ)
1.57x
Updated Oct 21, 2026
Book Value per Share (MRQ)
9.91CNYUpdated Oct 21, 2026
Total Assets
3.26BCNY
488.82M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.84BCNYFY2025 · Dec 31, 2025
Total Liabilities
1.74BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.42BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
231.13MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
1.51BCNYFY2025 · Dec 31, 2025
Cash
475.75MCNYFY2025 · Dec 31, 2025
Cash Equivalents
30.36MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
506.11MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
9.05MCNYFY2025 · Dec 31, 2025
Accounts Receivable
550.65MCNYFY2025 · Dec 31, 2025
Inventory
279.08MCNYFY2025 · Dec 31, 2025
Accounts Payable
326.32MCNYFY2025 · Dec 31, 2025
Short-term Debt
967.34MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
2.73MCNYFY2025 · Dec 31, 2025
Long-term Debt
208.36MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
5.11MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
153.71MCNYFY2025 · Dec 31, 2025
Retained Earnings
240.33MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.52BCNY
227.95M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
0.00CNYFY2025 · Dec 31, 2025
52-Week Low
24.50CNYUpdated Oct 21, 2026
52-Week High
98.47CNYUpdated Oct 21, 2026
52-Week Change
109.01%
vs all stocks
Updated Oct 21, 2026
Beta
1.55x
vs all stocks
Updated Oct 21, 2026
50-Day MA
56.70CNYUpdated Oct 21, 2026
200-Day MA
61.23CNYUpdated Oct 21, 2026
Avg 10-Day Volume
4.65MSharesUpdated Oct 21, 2026
Avg 30-Day Volume
3.66MSharesUpdated Oct 21, 2026
Diluted EPS (TTM)
-0.0500CNYUpdated Oct 21, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.41Profit Margin: -0.01
Financial Health
Altman Z-Score 3.35: safe zoneNotable
Altman Z-Score: 3.35
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Scale
Levered free cash flow is -$371.25M, lower than 95% of all stocks globallySignificant